Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
soluble interleukin-15
- Development stage
- Unknown
- Lead developer
- CytoImmune Therapeutics
- Modality
- Cytokines & Interferons → Recombinant Proteins and Enzymes, Cell Therapies
- Administration
- Intravenous
01
Overview
Soluble interleukin-15 (sIL15) is a cytokine that exists in two forms: as a monomer or as a heterodimeric complex in association with sIL-15Rα (sIL-15/IL-15Rα). It has been engineered into NK cells (called sIL15_TRACK NK cells) derived from umbilical cord blood to create a therapeutic approach for solid tumors. The soluble complex sIL-15/IL-15Rα displays more extended half-life and greater bioavailability compared to monomeric sIL-15 and interacts primarily with cells expressing the intermediate affinity IL-2Rβ/γc receptor. In cancer treatment, sIL15 enhances antitumor activity of effector cells.
- Other names
- sIL-15sIL15sIL 15
02
Targets
IL15RA (Interleukin-15 receptor subunit alpha)IL2RB (IL-2 receptor beta chain)
Beyond the preview
Go deeper on soluble interleukin-15.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on soluble interleukin-15.